Skip to main content

Table 1 Patient characteristics

From: Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation

Patient number Age (years) Diagnosis Days in ICU at study start SOFA at study start
1 58 Medical 13 14
2 56 Surgical 6 15
3 79 Medical 2 13
4 39 Medical 17 7
5 75 Medical 8 12
6 68 Neurological 2 6
7 69 Surgical 8 11
8 76 Surgical 2 11
9 84 Surgical 4 11
10 74 Medical 1 12
11 51 Medical 6 10
  1. Patients 1 to 6 were randomized to measure in the fed state at baseline (control), before being fed and glutamine supplemented, patients 7 to 12 were randomized to measure in the fed state and glutamine supplemented before feeding at baseline (control). SOFA, sequential organ failure assessment.